TapewireFind a company

person · Reporting owner

MacDonald Kelly

Disclosed activity across 2 companies

Tapewire entity
67090
SEC CIK
0001781117

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
IRONWOOD PHARMACEUTICALS INCIRWD · Entity 5213Chief Accounting OfficerDecember 04, 2020December 08, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

IRONWOOD PHARMACEUTICALS INC

Report date December 04, 2020 · Filed December 08, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect93,041 Ending reported balance After 2020-12-04 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2020-12-04 · Exercise / conversion · Acquired 5,639 · Balance 98,680

Row 2 · 2020-12-04 · Sale · Disposed 5,639 · Balance 93,041

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.12 · Expires 2026-03-01Direct0 Reported balance After 2020-12-04 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2020-12-04 · Exercise / conversion · Disposed 5,639 · Balance 0

F2: This option, granted as an annual performance award, is presently exercisable in full.

Filing footnotes · ownership attribution and instrument terms

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: This option, granted as an annual performance award, is presently exercisable in full.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

DYNAVAX TECHNOLOGIES CORP

Report date February 10, 2026 · Filed February 10, 2026

Section 16 reporting ended · disclosed 2026-02-10. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2026-02-10 transaction · row 1
1 source row

Row 1 · 2026-02-10 · Other · Disposed 60,204 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F3: Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of Common Stock held by the Reporting Person was tendered in exchange for the Offer Price.

Common Stock - Performance Stock UnitsSEC Table I · non-derivativeDirect0 Ending reported balance After 2026-02-10 transaction · row 5
4 source rows · reconciled sequence

Row 2 · 2026-02-10 · Grant · Acquired 46,430 · Balance 46,430

F4: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person in 2024, which vest based on how the Issuer's total stockholder return compares to the total stockholder return of an indexed group of companies ("rTSR") over a performance period ending on December 31, 2026.

Row 3 · 2026-02-10 · Disposition to issuer · Disposed 46,430 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such PSU award immediately prior to the Effective Time based on attainment of the performance goal at 150% of the target level, without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any PSU award that was granted in calendar year 2025, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Row 4 · 2026-02-10 · Grant · Acquired 42,424 · Balance 42,424

F6: Represents PSUs previously granted to the Reporting Person in 2025, which vest based on rTSR over a performance period ending on December 31, 2027.

Row 5 · 2026-02-10 · Disposition to issuer · Disposed 42,424 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such PSU award immediately prior to the Effective Time based on attainment of the performance goal at 150% of the target level, without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any PSU award that was granted in calendar year 2025, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.90Direct0 Reported balance After 2026-02-10 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-02-10 · Disposition to issuer · Disposed 350,000 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.74Direct0 Reported balance After 2026-02-10 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2026-02-10 · Disposition to issuer · Disposed 90,500 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.12Direct0 Reported balance After 2026-02-10 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2026-02-10 · Disposition to issuer · Disposed 100,000 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.48Direct0 Reported balance After 2026-02-10 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2026-02-10 · Disposition to issuer · Disposed 65,000 · Balance 0

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.69Direct0 Reported balance After 2026-02-10 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2026-02-10 · Disposition to issuer · Disposed 70,000 · Balance 0

F8: The stock option was granted to the Reporting Person in 2025.

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-02-10 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2026-02-10 · Disposition to issuer · Disposed 15,476 · Balance 0

F9: The restricted stock units ("RSUs") were granted on February 15, 2024, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 15, 2024.

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F10: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-02-10 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2026-02-10 · Disposition to issuer · Disposed 28,283 · Balance 0

F11: The RSUs were granted on February 13, 2025, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 13, 2025.

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F10: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F3: Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of Common Stock held by the Reporting Person was tendered in exchange for the Offer Price.

F4: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person in 2024, which vest based on how the Issuer's total stockholder return compares to the total stockholder return of an indexed group of companies ("rTSR") over a performance period ending on December 31, 2026.

F5: Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such PSU award immediately prior to the Effective Time based on attainment of the performance goal at 150% of the target level, without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any PSU award that was granted in calendar year 2025, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F6: Represents PSUs previously granted to the Reporting Person in 2025, which vest based on rTSR over a performance period ending on December 31, 2027.

F7: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F8: The stock option was granted to the Reporting Person in 2025.

F9: The restricted stock units ("RSUs") were granted on February 15, 2024, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 15, 2024.

F10: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F11: The RSUs were granted on February 13, 2025, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 13, 2025.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerRestricted Stock Units · Derivative 28,283 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 12

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,283 shares

Expires not disclosed

F11 · derivative.exercise_price: The RSUs were granted on February 13, 2025, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 13, 2025.

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F10 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F10 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F10 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerRestricted Stock Units · Derivative 15,476 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 11

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,476 shares

Expires not disclosed

F9 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on February 15, 2024, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 15, 2024.

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F10 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F10 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F10 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerStock Option (Right to Buy) · Derivative 70,000 Not disclosed Strike: $12.69 Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 10

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 70,000 shares

Expires not disclosed

F8 · security: The stock option was granted to the Reporting Person in 2025.

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7 · price: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerStock Option (Right to Buy) · Derivative 65,000 Not disclosed Strike: $12.48 Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 9

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 65,000 shares

Expires not disclosed

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7 · price: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerStock Option (Right to Buy) · Derivative 100,000 Not disclosed Strike: $11.12 Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 8

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7 · price: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerStock Option (Right to Buy) · Derivative 90,500 Not disclosed Strike: $12.74 Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 7

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 90,500 shares

Expires not disclosed

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7 · price: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerStock Option (Right to Buy) · Derivative 350,000 Not disclosed Strike: $8.90 Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · derivative · entry 6

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 350,000 shares

Expires not disclosed

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F7 · price: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

F7 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerCommon Stock - Performance Stock Units 42,424 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · nonDerivative · entry 5

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F5 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such PSU award immediately prior to the Effective Time based on attainment of the performance goal at 150% of the target level, without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any PSU award that was granted in calendar year 2025, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantCommon Stock - Performance Stock Units 42,424 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · nonDerivative · entry 4

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,424

F6 · price: Represents PSUs previously granted to the Reporting Person in 2025, which vest based on rTSR over a performance period ending on December 31, 2027.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Disposition to issuerCommon Stock - Performance Stock Units 46,430 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · nonDerivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F5 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such PSU award immediately prior to the Effective Time based on attainment of the performance goal at 150% of the target level, without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any PSU award that was granted in calendar year 2025, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantCommon Stock - Performance Stock Units 46,430 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,430

F4 · price: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person in 2024, which vest based on how the Issuer's total stockholder return compares to the total stockholder return of an indexed group of companies ("rTSR") over a performance period ending on December 31, 2026.

Read SEC document
February 10, 2026 Filed Feb 10, 2026 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 OtherCommon Stock 60,204 Not disclosed Not disclosed
Disclosure

SEC source: 0001781117-26-000002 · form4-02102026_040217.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

F2 · kind: Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

F3 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of Common Stock held by the Reporting Person was tendered in exchange for the Offer Price.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Tax withholdingCommon Stock 36,141 $15.38 $555,848.58
Disclosure

SEC source: 0001628280-25-058992 · wk-form4_1767042911.xml · nonDerivative · entry 4

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,204

F4 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of PSUs and RSUs.

Read SEC document
December 23, 2025 Filed Dec 29, 2025 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 14,141 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-058992 · wk-form4_1767042911.xml · derivative · entry 6

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,282

Underlying: Common Stock · 14,141 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · kind: On December 23, 2025 (the "Effective Date"), in connection with the execution of an Agreement and Plan of Merger dated as of the Effective Date (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, the Board of Directors of the Issuer approved acceleration of vesting of certain performance-based restricted stock units ("PSUs") and restricted stock units ("RSUs") previously granted to the Reporting Person, effective as of the Effective Date.

F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: The RSUs were granted on February 13, 2025, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 13, 2025.

F6 · derivative.expiration_date: The RSUs were granted on February 13, 2025, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 13, 2025.

Read SEC document
December 23, 2025 Filed Dec 29, 2025 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 15,477 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-058992 · wk-form4_1767042911.xml · derivative · entry 5

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,477

Underlying: Common Stock · 15,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · kind: On December 23, 2025 (the "Effective Date"), in connection with the execution of an Agreement and Plan of Merger dated as of the Effective Date (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, the Board of Directors of the Issuer approved acceleration of vesting of certain performance-based restricted stock units ("PSUs") and restricted stock units ("RSUs") previously granted to the Reporting Person, effective as of the Effective Date.

F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The RSUs were granted on February 15, 2024, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 15, 2024.

F5 · derivative.expiration_date: The RSUs were granted on February 15, 2024, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 15, 2024.

Read SEC document
December 23, 2025 Filed Dec 29, 2025 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 14,141 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-058992 · wk-form4_1767042911.xml · nonDerivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,345

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On December 23, 2025 (the "Effective Date"), in connection with the execution of an Agreement and Plan of Merger dated as of the Effective Date (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, the Board of Directors of the Issuer approved acceleration of vesting of certain performance-based restricted stock units ("PSUs") and restricted stock units ("RSUs") previously granted to the Reporting Person, effective as of the Effective Date.

F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 23, 2025 Filed Dec 29, 2025 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 15,477 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-058992 · wk-form4_1767042911.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On December 23, 2025 (the "Effective Date"), in connection with the execution of an Agreement and Plan of Merger dated as of the Effective Date (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, the Board of Directors of the Issuer approved acceleration of vesting of certain performance-based restricted stock units ("PSUs") and restricted stock units ("RSUs") previously granted to the Reporting Person, effective as of the Effective Date.

F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 23, 2025 Filed Dec 29, 2025 16:15 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantCommon Stock 37,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-058992 · wk-form4_1767042911.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,727

F1 · kind: On December 23, 2025 (the "Effective Date"), in connection with the execution of an Agreement and Plan of Merger dated as of the Effective Date (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent, the Board of Directors of the Issuer approved acceleration of vesting of certain performance-based restricted stock units ("PSUs") and restricted stock units ("RSUs") previously granted to the Reporting Person, effective as of the Effective Date.

F2 · price: Represents PSUs previously granted to the Reporting Person that vest based on how the Issuer's total stockholder return compares to the total stockholder return of an indexed group of companies ("rTSR") over a performance period ending on December 31, 2025. Each PSU represents a contingent right to receive one share of common stock. On the Effective Date, the Board of Directors of the Issuer determined that these PSUs (which represent 125% of the target number of PSUs) were earned according to achievement of the rTSR performance condition over a shortened performance period, with the Issuer's total stockholder return determined based on the amount payable for a share of the Issuer's common stock pursuant to the Merger Agreement ($15.50), and approved such acceleration of vesting of the earned PSUs.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 19:29 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 15,477 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000055 · wk-form4_1740097777.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,953

Underlying: Common Stock · 15,477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F1 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F1 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F1 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 19:29 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Tax withholdingCommon Stock 4,975 $12.93 $64,326.75
Disclosure

SEC source: 0001029142-25-000055 · wk-form4_1740097777.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,227

F2 · shares: Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 19:29 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 15,477 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000055 · wk-form4_1740097777.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,202

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F1 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:10 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantRestricted Stock Unit · Derivative 42,424 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000035 · wk-form4_1739916608.xml · derivative · entry 6

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,424

Underlying: Common Stock · 42,424 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 13, 2025.

F5 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 13, 2025.

F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 13, 2025.

F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 13, 2025.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:10 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantStock Option (Right to Buy) · Derivative 70,000 Not disclosed Strike: $12.69 Not disclosed
Disclosure

SEC source: 0001029142-25-000035 · wk-form4_1739916608.xml · derivative · entry 5

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2032-02-13

F4 · price: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 13, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

F3 · derivative.exercise_date: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 13, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:10 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 16,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000035 · wk-form4_1739916608.xml · derivative · entry 4

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

F1 · price: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

F1 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

F1 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:10 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantRestricted Stock Unit · Derivative 16,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000035 · wk-form4_1739916608.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

F1 · price: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

F1 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

F1 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:10 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Tax withholdingCommon Stock 5,318 $12.69 $67,485.42
Disclosure

SEC source: 0001029142-25-000035 · wk-form4_1739916608.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,725

F2 · shares: Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:10 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 16,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000035 · wk-form4_1739916608.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:59 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 5,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000022 · wk-form4_1739397585.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:59 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Tax withholdingCommon Stock 1,997 $13.20 $26,360.40
Disclosure

SEC source: 0001029142-25-000022 · wk-form4_1739397585.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,043

F2 · shares: Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:59 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 5,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001029142-25-000022 · wk-form4_1739397585.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 15, 2024 Filed Feb 20, 2024 16:44 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantRestricted Stock Unit · Derivative 46,430 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-003548 · doc4.xml · derivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,430

Underlying: Common Stock · 46,430 shares

Expires not disclosed

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F1 · kind: Code A: Grant, award or other acquisition

F3 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 16:44 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantStock Options (Right to Buy) · Derivative 65,000 $0.00 Strike: $12.48 $0.00
Disclosure

SEC source: 0001209191-24-003548 · doc4.xml · derivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2031-02-15

F1 · kind: Code A: Grant, award or other acquisition

F2 · derivative.exercise_date: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Read SEC document
February 12, 2024 Filed Feb 13, 2024 17:16 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Tax withholdingCommon Stock 2,985 $12.82 $38,267.70
Disclosure

SEC source: 0001209191-24-003196 · doc4.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,707

F3 · kind: Code F: Payment of exercise price or tax liability by delivering or withholding securities

F4 · shares: Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.

Read SEC document
February 10, 2024 Filed Feb 13, 2024 17:16 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 5,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-003196 · doc4.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,333

Underlying: Common Stock · 5,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · kind: Code M: Exercise or conversion of derivative security

F2 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 10, 2024 Filed Feb 13, 2024 17:16 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 5,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-003196 · doc4.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Code M: Exercise or conversion of derivative security

F2 · shares: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 27, 2023 Filed Mar 1, 2023 16:52 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionRestricted Stock Unit · Derivative 5,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-014170 · doc4.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,666

Underlying: Common Stock · 5,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 27, 2023 Filed Mar 1, 2023 16:52 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Tax withholdingCommon Stock 2,975 $10.36 $30,821.00
Disclosure

SEC source: 0001209191-23-014170 · doc4.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,359

F2 · shares: The reporting person is reporting the withholding by Dynavax Technologies Corporation of 2,975 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 27, 2023.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 16:52 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 Exercise / conversionCommon Stock 5,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-014170 · doc4.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F1 · price: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 16, 2023 Filed Feb 21, 2023 17:25 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantStock Option (Right to Buy) · Derivative 100,000 Not disclosed Strike: $11.12 Not disclosed
Disclosure

SEC source: 0001209191-23-011297 · doc4.xml · derivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-02-15

F1 · price: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

F1 · derivative.exercise_date: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 21:09 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantRestricted Stock Unit · Derivative 16,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-009592 · doc4.xml · derivative · entry 2

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

F2 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022

Read SEC document
February 10, 2022 Filed Feb 14, 2022 21:09 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantStock Option (Right to Buy) · Derivative 90,500 $0.00 Strike: $12.74 $0.00
Disclosure

SEC source: 0001209191-22-009592 · doc4.xml · derivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,500

Underlying: Common Stock · 90,500 shares

Expires 2029-02-09

F1 · derivative.exercise_date: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 19:58 UTC DYNAVAX TECHNOLOGIES CORP DVAX · Entity 66930 GrantStock Option (Right to Buy) · Derivative 350,000 $0.00 Strike: $8.90 $0.00
Disclosure

SEC source: 0001209191-21-016520 · doc4.xml · derivative · entry 1

MacDonald Kelly · CIK 0001781117 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2028-02-29

F1 · price: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of March 1, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

F1 · derivative.exercise_date: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of March 1, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Read SEC document
December 04, 2020 Filed Dec 8, 2020 21:01 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,639 $0.00 Strike: $9.12 $0.00
Disclosure

SEC source: 0001209191-20-062229 · doc4.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,639 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

Read SEC document
December 04, 2020 Filed Dec 8, 2020 21:01 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 SaleClass A Common Stock 5,639 $12.50 $70,487.50
Disclosure

SEC source: 0001209191-20-062229 · doc4.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,041

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
December 04, 2020 Filed Dec 8, 2020 21:01 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 Exercise / conversionClass A Common Stock 5,639 $9.12 $51,427.68
Disclosure

SEC source: 0001209191-20-062229 · doc4.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2020 Filed Nov 13, 2020 21:02 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,561 $0.00 Strike: $9.31 $0.00
Disclosure

SEC source: 0001209191-20-058270 · doc4.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 3,561 shares

Expires 2025-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option, granted as a promotion award, is presently exercisable in full.

Read SEC document
November 11, 2020 Filed Nov 13, 2020 21:02 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 SaleClass A Common Stock 3,561 $11.75 $41,841.75
Disclosure

SEC source: 0001209191-20-058270 · doc4.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,041

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
November 11, 2020 Filed Nov 13, 2020 21:02 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 Exercise / conversionClass A Common Stock 3,561 $9.31 $33,152.91
Disclosure

SEC source: 0001209191-20-058270 · doc4.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:10 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 SaleClass A Common Stock 100 $10.92 $1,092.00
Disclosure

SEC source: 0001209191-20-057611 · doc4.xml · nonDerivative · entry 3

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,041

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 15, 2017.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 21:10 UTC IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 SaleClass A Common Stock 825 $10.92 $9,009.00
Disclosure

SEC source: 0001209191-20-057611 · doc4.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,141

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.